High-Dose Chemotherapy without Stem Cell Transplantation for Refractory Childhood Systemic Lupus Erythematosus

Publisher： Karger

E-ISSN： 1421-9794|54|5|331-335

ISSN： 0009-3157

Source： Chemotherapy, Vol.54, Iss.5, 2008-08, pp. : 331-335

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase I Trial of High-Dose Chemotherapy Combining Topotecan plus Cyclophosphamide with Hematopoietic Stem Cell Transplantation for Ovarian Cancer: The ITOV 01bis Study

By  

Chemotherapy, Vol. 61, Iss. 1, 2015-0 ,pp. : 15-22

Karger

Access to resources Recommend Favorite

Conditioning Regimens Including High-Dose Busulfan Cause a High Incidence of Transplant-Related Mortality after Myeloablative Stem Cell Transplantation

By  

Chemotherapy, Vol. 50, Iss. 4, 2004-10 ,pp. : 178-183

Karger

Access to resources Recommend Favorite

Dysregulation of Cell Death and Its Epigenetic Mechanisms in Systemic Lupus Erythematosus

By Wu Haijing   Fu Siqi   Zhao Ming   Lu Liwei   Lu Qianjin  

Molecules, Vol. 22, Iss. 1, 2016-12 ,pp. : 30-30

MDPI

Access to resources Recommend Favorite

Roles of B Cell-Intrinsic TLR Signals in Systemic Lupus Erythematosus

By Ma Kongyang   Li Jingyi   Fang Yongfei   Lu Liwei  

International Journal of Molecular Sciences, Vol. 16, Iss. 6, 2015-06 ,pp. : 13084-13105

MDPI

Access to resources Recommend Favorite

Regulation of T Cell Activation and Differentiation by Extracellular Vesicles and Their Pathogenic Role in Systemic Lupus Erythematosus and Multiple Sclerosis

By Ulivieri Cristina   Baldari Cosima T.  

Molecules, Vol. 22, Iss. 2, 2017-02 ,pp. : 225-225

MDPI

Access to resources Recommend Favorite